You have not yet registered? Get your account for free.
Forgot Password? We will send you a reset link
25 April 2024
Analystenkonferenz zum Finanzjahr 2023 – März 2024
28 March 2024
Geschäftsbericht 2023
Full Year Results 2023 – March 2024
Annual financial report 2023
6 November 2023
Q3 statement / Q3 financial report 2023
2 November 2023
Quartalsergebnisse Q1-Q3 – November 2023
Quarterly Results Q1-Q3 – November 2023
10 August 2023
Half-yearly financial report 2023
9 May 2023
Q1 statement / Q1 financial report 2023
23 March 2023
Annual financial report 2022
Full Year Results 2022– March 2023
Geschäftsbericht 2022
Remunerations Report 2022
Geschäftsbericht 2022 (ESEF)
Analystenkonferenz zum Finanzjahr 2022 – März 2023
Vergütungsbericht 2022
14 November 2022
Qartalsergebnisse Q1-Q3 – November 2022
Q3 statement / Q3 financial report 2022
Quarterly Results Q1-Q3 – November 2022
11 August 2022
Half-yearly financial report 2022
Half Year Results 2022 – August 2022
Präsentation zum Halbjahr 2022 – August 2022
30 June 2022
Biotest at Grifols 2022 Investor & Analyst Day – June 2022
Biotest at Grifols 2022 Investor & Analyst Day – Juni 2022
5 May 2022
Q1 statement / Q1 financial report 2022
19 April 2024
Biotest AG opens 12th plasma collection centre in Germany
Biotest Aktiengesellschaft: Bekanntmachung der Einberufung zur Hauptversammlung am 07.05.2024 in Frankfurt am Main mit dem Ziel der europaweiten Verbreitung gemäß §121 AktG
Biotest AG increased sales by 32% in the financial year 2023
29 February 2024
Biotest achieves EBIT forecast for 2023
28 February 2024
Karl Lauterbach visits Biotest AG’s plasma donation centre in Cologne and emphasises important contribution to patient care
14 February 2024
Biotest successfully meets primary endpoint in phase III trial with Fibrinogen concentrate
07
May 24
Annual General Meeting
Publication quarterly statement (call-date Q1)
30
Jul 24
Publication half-yearly financial report
05
Nov 24
Publication quarterly statement (call-date Q3)
